Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05173519Not ApplicableSuspended

Omnibond vs Dermabond

Role: lead

NCT05440032Unknown

LE as a Marker for Periprosthetic Joint Infection

Role: lead

NCT05247281Not ApplicableUnknown

NGS vs Culture Outcomes for Treatment of PJI

Role: lead

NCT05166642Not ApplicableSuspended

Bandgrip vs Traditional Sutures TJA

Role: lead

NCT05434260Not ApplicableUnknown

Surgiphor vs Saline Joints

Role: lead

NCT05617729Not ApplicableCompleted

A Clinical Simulation Study of a Test Material on the Anterior Nares

Role: lead

NCT05608382Not ApplicableCompleted

Effect of an Antiseptic Solution on the Skin Microbiome

Role: lead

All 7 trials loaded